Abstract Body

Cryptococcosis remains a leading cause of meningitis and mortality among people living with HIV worldwide. This study sought to evaluate laboratory-based cryptococcal antigen (CrAg) reflex testing and a clinic-based point-of-care (POC) CrAg screening intervention for preventing meningitis and mortality.

We conducted a prospective pre-post intervention study of adults presenting for HIV testing in Umlazi Township, South Africa. Participants were enrolled during three phases of CrAg testing – CrAg testing ordered by a clinician (‘Clinician-directed testing’; 2013-2015); routine lab-based CrAg reflex testing for blood samples with CD4 <100 cells/mm3 ('Lab reflex testing'; 2015-2017), and a clinic-based intervention with POC CD4 testing and POC CrAg testing among persons with CD4 ?200 cells/mm3 in addition to background standard of care routine reflex testing among those with CD4 <100 cells/mm3 ('Clinic-based testing'; 2017-2019). The laboratory and clinical teams performed serum CrAg by enzyme immunoassay and lateral flow assay (Immy Diagnostics, Norman, USA). We followed participants for up to 14 months to assess the outcomes of ART and fluconazole treatment initiation, cryptococcal meningitis, hospitalization and mortality by baseline CrAg positivity.

3,105 (39.4%) of 7,877 people screened were HIV-positive, of whom 908 had CD4 ?200 cells/mm3 and were included in analyses. Compared to clinician-directed testing, lab reflex and clinic-based testing increased CrAg screening (p<0.001) and diagnosis of Cryptococcus (CrAg+) (p=0.020). Compared to clinician-directed testing, clinic-based CrAg testing increased the number of participants diagnosed with cryptococcal meningitis (p=0.038). Comparing clinic-based testing to lab reflex testing, there was no significant difference in the cumulative incidence of cryptococcal meningitis (4.5% compared to 4.1%; p=0.829) or mortality (8.1% compared to 9.9%; p=0.463).

Among ambulatory adults recently diagnosed with HIV in South Africa, lab reflex and clinic-based CrAg testing facilitated diagnosis of HIV-associated cryptococcosis and fluconazole initiation, compared to clinician-directed CrAg testing. Clinic-based CrAg testing increased the number diagnosed with cryptococcal meningitis, but did not alter hospitalization or mortality rates. In this non-randomized cohort, clinical outcomes were similar between lab reflex testing and clinic-based point-of-care CrAg testing.